What is the recommended dosage of co-amoxiclav (amoxicillin/clavulanic acid) syrup in milligrams per kilogram per day?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Co-Amoxiclav Syrup Dosing in Pediatrics

The recommended dosage of co-amoxiclav syrup is 45 mg/kg/day of the amoxicillin component divided into 2 doses for standard infections, or 80-90 mg/kg/day with 6.4 mg/kg/day of clavulanate divided into 2 doses for high-risk situations or severe infections. 1

Standard Dosing Framework

For uncomplicated infections in children ≥2 years old without recent antibiotic exposure:

  • 45 mg/kg/day of amoxicillin component in 2 divided doses 1, 2
  • This applies to mild-to-moderate respiratory infections including acute otitis media and uncomplicated sinusitis 1
  • Maximum single dose is 2000 mg 3

Age-Based Suspension Dosing

For practical administration using standard suspension formulations 1:

  • <1 year: 2.5 ml/kg of 125/31 suspension three times daily 1
  • 1-6 years: 5 ml of 125/31 suspension three times daily 1
  • >6 years: 5 ml of 250/62 suspension three times daily 1

High-Dose Regimen Indications

Use 80-90 mg/kg/day of amoxicillin with 6.4 mg/kg/day of clavulanate in 2 divided doses when any of these risk factors are present: 1, 2

  • Age <2 years 1, 2
  • Attendance at childcare 1, 2
  • Antibiotic use within previous 30 days 1, 2
  • Moderate-to-severe illness 1, 2
  • Concurrent conjunctivitis (otitis-conjunctivitis syndrome) 1
  • Geographic areas with >10% penicillin-nonsusceptible S. pneumoniae 1

Critical Dosing Considerations

The clavulanate component must be maintained at 6.4 mg/kg/day for high-dose regimens to ensure adequate β-lactamase inhibition. 1, 3 This ratio (14:1 amoxicillin to clavulanate) is specifically designed to minimize diarrhea while providing coverage against β-lactamase-producing H. influenzae and M. catarrhalis 1, 2.

Common Pitfalls to Avoid

  • Do not use standard-dose amoxicillin-clavulanate for high-risk patients - the clavulanate concentration will be inadequate 1
  • Do not exceed 2000 mg amoxicillin per single dose regardless of weight 3, 2
  • Research shows that standard 40 mg/kg/day dosing is inadequate for resistant S. pneumoniae, particularly during viral coinfection 4

Duration of Therapy

  • Acute otitis media: 10 days for children <2 years; 5-7 days for older children with uncomplicated cases 1
  • Acute bacterial sinusitis: Minimum 10 days total, continuing 7 days after symptom resolution 1, 3
  • Most other infections: 7-10 days 2

Special Clinical Scenario: Treatment Failure

If the patient fails to improve after 48-72 hours on standard-dose amoxicillin-clavulanate, escalate to ceftriaxone 50 mg/kg IM or IV for 3 days 1. This provides coverage for multidrug-resistant organisms while awaiting culture results.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Amoxicillin-Clavulanate Dosage Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Co-Amoxiclav Dosing Guidelines for Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.